Cellebrite DI (CLBT) Return on Sales (2020 - 2025)

Cellebrite DI's Return on Sales history runs 6 years deep, the most recent figure standing at 0.0% for Q4 2025.

• On a quarterly basis, Return on Sales changed 0.0% year-over-year to 0.0% in Q4 2025; TTM through Dec 2025 was 0.0%, a 1.0% increase from a year earlier, with the FY2025 full-year figure at 0.0%, up 1.0% from the prior year.
• Return on Sales climbed to 0.0% in Q4 2025 per CLBT's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q1 2022 and bottomed at 0.02% in Q3 2024.
• The 5-year median for Return on Sales is 0.0% (2021), against an average of 0.0%.
• Across the five-year window, Return on Sales decreased 2 bps in 2024 and climbed 2 bps in 2025, its largest moves.
• Year by year, Return on Sales stood at 0.01% in 2021, then plunged by 87 bps to 0.0% in 2022, then slumped by 265 bps to 0.0% in 2023, then soared by 212 bps to 0.0% in 2024, then declined by 7 bps to 0.0% in 2025.
• Per Business Quant, the three latest CLBT Return on Sales figures stand at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).